Navigation Links
Wyeth Provides Regulatory Update on Prevnar 13* in the United States
Date:8/11/2009

COLLEGEVILLE, Pa., Aug. 11 /PRNewswire-FirstCall/ -- Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE), announced it received notice that the action date for the U.S. Food and Drug Administration's (FDA) review of the Biologics License Application (BLA) for Prevnar 13(TM), (Pneumococcal 13-valent Conjugate Vaccine [Diphtheria CRM197 Protein]) has been extended from September 30, 2009, to December 30, 2009. In response to an FDA request, Wyeth submitted additional analytical method validation and specification information relating to physical/chemical properties of the product in late July. FDA considered this to be a major amendment and, as a result, they have elected to extend the review cycle for Prevnar 13 by 90 days. Prevnar 13 is under review for active immunization of infants and young children for the prevention of invasive disease and otitis media caused by 13 Streptococcus pneumoniae (S. pneumoniae) serotypes.

"This is a significant application that is under priority review and we are working closely with the FDA on the review, including conduct of the pre-approval inspections," says Emilio Emini, Ph.D., executive vice president, Vaccine Research and Development, Wyeth Pharmaceuticals. "Priority review designation is given to products that, if approved, would be a significant therapeutic or public health advance. We continue to believe that our application supports the approval of Prevnar 13."

Prevnar 13(TM) is based on the scientific foundation of Prevnar(R) (Pneumococcal 7-valent Conjugate Vaccine [Diphtheria CRM197 Protein]), the standard in pneumococcal disease prevention for infants and young children. It contains the seven serotypes in Prevnar (4, 6B, 9V, 14, 18C, 19F and 23F), plus six additional serotypes (1, 3, 5, 6A, 7F and 19A) respon
'/>"/>

SOURCE Wyeth Pharmaceuticals
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. Wyeth Announces Stockholder Approval of Pfizer Merger at 2009 Annual Meeting
2. Trubion Pharmaceuticals Announces Extension of Research Period Under Its Wyeth Collaboration
3. Wyeth Announces Holder Right to Surrender Convertible Debentures
4. Wyeth Declares Common Stock Dividend
5. New Phase 3 Data Continue to Indicate that Wyeths Investigational 13-valent Vaccine Has the Potential to Broaden Coverage Against Pneumococcal Disease
6. Wyeth Sets Webcast and Conference Call For 2009 Second Quarter Earnings
7. Wyeth Announces Full Redemption of $2 Convertible Preferred Stock
8. Wyeth Declares Common and Preferred Stock Dividends
9. Wyeth Sets Webcast and Conference Call for 2009 First Quarter Earnings
10. Wyeth to Present at the SG Cowen & Co. 29th Annual Healthcare Conference
11. Wyeth to Present at the Goldman Sachs Healthcare CEOs Unscripted Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/3/2015)... ... September 03, 2015 , ... The latest addition to the Mettler-Toledo ... verifies labels automatically. Companies in the pharmaceutical and healthcare industry can use the LSS ... per minute. The Label Serialization Station can be fully integrated into the production line ...
(Date:9/3/2015)... 2015  Guardant Health®, the leader in liquid ... performance and clinical utility of Guardant360® on lung ... poster presentations at the International Association for the ... Lung Cancer. These abstracts were submitted by MD ... the University of Chicago; Sarah Cannon Research Institute; ...
(Date:9/3/2015)... /PRNewswire/ - bioLytical Laboratories Inc., a leader in rapid ... Sensitivity of a rapid point of care assay for ... for HIV gp41 IgM antibodies " has been published ... INSTI,s ability to detect early HIV infection.  ... th annual International AIDS Society Conference, which highlighted ...
(Date:9/3/2015)... , September 3, 2015 According ... by System (LC (HPLC, UHPLC, Flash), GC, Other Components ... Syringe Filters, Vials) - Analysis & Global Forecasts to ... expected to reach around 9.223 Billion by 2020 from ... 5.5%. Browse 141 tables and 36 figures ...
Breaking Biology Technology:Print and Verify Labels On The Production Line With New Label Serialization Stations 2Print and Verify Labels On The Production Line With New Label Serialization Stations 3Leading Cancer Centers to Present Clinical Utility Data For Guardant360 At IASLC's 16th World Conference on Lung Cancer in Denver Sept. 6-9 2Leading Cancer Centers to Present Clinical Utility Data For Guardant360 At IASLC's 16th World Conference on Lung Cancer in Denver Sept. 6-9 3Leading Cancer Centers to Present Clinical Utility Data For Guardant360 At IASLC's 16th World Conference on Lung Cancer in Denver Sept. 6-9 4bioLytical's INSTI HIV Test Detects gp41 specific IgM Antibodies 2bioLytical's INSTI HIV Test Detects gp41 specific IgM Antibodies 3Chromatography Instruments Market Worth $ 9.223 Billion by 2020 2Chromatography Instruments Market Worth $ 9.223 Billion by 2020 3Chromatography Instruments Market Worth $ 9.223 Billion by 2020 4
... A decline in research revenue led Third Wave ... 54 cents a share, but because the loss was expected share ... transition, Third Wave expected something of a rough patch. It has ... and a new CEO. , ,Third Wave's 2005 revenue was ...
... Information technology suffers from one bugbear above all: ... on Wednesday night and explored by panelists and attendees of ... is something that will win," said Frank Timons, an analysit ... is plagued by "too many applications, too many vendors, too ...
... audience at Fusion2006. Madison, Wis. ... businesses' core competencies, said Delphi Group founder and CEO ... "No-Fear Management: Innovating in a Culture of Change." , ... that the passion we have about vision and leadership ...
Cached Biology Technology:Simplicity appeals to CIOs, but it's no easy task 2Simplicity appeals to CIOs, but it's no easy task 3
(Date:8/17/2015)... -- NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" or the ... mobile commerce market and creator of the Wocket® smart ... The new marketing campaign is being spearheaded by an ... ( http://amplitudemarketing.com/ ) and TPMG ( http://tmpg.com/ ). ... driven marketing and brand awareness and has a client ...
(Date:8/12/2015)... SAN JOSE, Calif. , Aug. 12, 2015 ... leading developer of human interface solutions, today announced ... the recently announced Match-in-Sensor solution, have officially been ... (FIDO) Alliance. As part of the certification, Synaptics, ... the FIDO 1.0 Universal Authentication Framework (UAF) standard ...
(Date:8/6/2015)... 6, 2015  Today, U.S. Congressman Mike ... ™ to learn firsthand how Silicon Valley technologies ... is a world leader in multi-factor identity management ... helping federal agencies and commercial organizations achieve new ... "The vast majority of network breaches can ...
Breaking Biology News(10 mins):NXT-ID, Inc. Launches Sales Campaign for Wocket Smart Wallet with Award Winning Marketing Team 2NXT-ID, Inc. Launches Sales Campaign for Wocket Smart Wallet with Award Winning Marketing Team 3Synaptics Announces FIDO Certification of Natural ID Fingerprint Solutions 2Synaptics Announces FIDO Certification of Natural ID Fingerprint Solutions 3Rep. Honda to Visit Crossmatch in Redwood City 2
... Marine conservationists from Plymouth University, and the Universidad Federal ... years analysing the diversity and density of coral colonies ... with the catastrophic El Nio event of 1997-98, creating ... long-term impact a major environmental incident of this nature ...
... in ecology has centered on the role of microbes ... of print in the journal Applied and Environmental ... Sydney, Australia, and collaborators show how changes in the ... mitigation at ecosystem levels. "Ecological theories developed ...
... grades haunt your students. A new study in the ... biology courses is a strong predictor of performance in high-level ... students over 7 years, researchers from Kansas State University found ... in a rigorous genetics course. This result was not surprising, ...
Cached Biology News:Catastrophic climatic events leave corals facing a decade-long fight for recovery 2
Recombinant Ovine IFN Tau. Active on sheep, cow, human and mouse cells. Activity: 5.7 x 10 7 u/mg...
... has established an expertise in the forefront ... solid support synthesis and synthesis in solution. ... Mass Spectrometry and analytical HPLC at no ... that meet the highest quality standard. , ...
... Electron RapidStak provides valuable walk-away time and ... buffer nest technology for parallel processing of ... fast, reliable automation for any laboratory in ... The RapidStak can be set-up within minutes ...
Recombinant Rhesus Monkey IFN Alpha Activity: 2.9 x 10 8 u/mg...
Biology Products: